Misguided cancer goal

“Misguided Cancer Goal.” Editorial, Nature

An influential US advocacy group has set a deadline to beat breast cancer by 2020. But it puts public trust at risk by promising an objective that science cannot yet deliver. Hope is not a good strategy, in life or in disease research. So the setting of goals, and the . . . → Read More: Misguided Cancer Goal

Research Brief --

Dr. Patricia Steeg

Patricia S. Steeg, chief of the Center for Cancer Research at the National Cancer Institute, argues in Nature [2012, 485, S58a] that most people with breast cancer die as a result of metastases (spread). Clinical trials, however, are only designed to evaluate a drug’s ability to shrink established tumors rather . . . → Read More: Research Brief — “The Right Trials”